The links below take you out of the MS-Selfie website to Prof G’s MS-Selfie newsletter and research archive.
Case study: Switching from ocrelizumab to alemtuzumab
Case study: Switching from natalizumab to HSCT or alemtuzumab
Anti-CD20s (ocrelizumab, ofatumumab, ublituximab)
Fumarates (dimethyl fumarate and diroximel fumarate)
HSCT (haematopoietic stem cell transplant)
The link below takes you out of the MS-Selfie website to Prof G’s MS-Selfie newsletter and research archive.
Case study: Switching from natalizumab to HSCT or alemtuzumab
Sphingosine 1-phosphate (S1P) modulators (fingolimod, siponimod, ozanimod, ponesimod)